DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bumex (Bumetanide) - Hypotension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypotension (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bumex (Bumetanide) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bumex side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26

Patient: male

Reactions: Hypotension, Procedural Complication

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Placebo
    Dosage: (df)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-15

Saxagliptin
    Dosage: (df)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-15

Humalog
    Dosage: (df)
    Indication: Type 2 Diabetes Mellitus

Bumex
    Dosage: (df)

Other drugs received by patient: Anti-Coagulants (Unknown); Statin (Unknown); Ezetimibe (Unknown); Diuretics (Unknown); Alpha Blockers; Other Anti-Platelet Agents (Unknown); Angiotensin Converting Enzyme Inhibitor; Beta-Blocker; Aspirin



Possible Bumex side effects in male

Reported by a physician from United States on 2012-03-23

Patient: male, weighing 87.3 kg (192.1 pounds)

Reactions: Dehydration, Hypotension, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Enalapril Maleate
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    Start date: 2012-02-16
    End date: 2012-03-05

Spironolactone
    Dosage: 50 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-12-15

Spironolactone
    Indication: Hypertension

Coreg
    Dosage: 3.125 mg, bid
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2012-01-11

Bumex
    Indication: Hypertension

Blinded NO Treatment Received
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    Start date: 2012-02-16
    End date: 2012-03-05

Valsartan
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    Start date: 2012-02-16
    End date: 2012-03-05

Bumex
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-20

Other drugs received by patient: Aspirin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017